Tech and Science

Independent financial news covering Finance, Industries, Technology, Crypto, and more. Delivering accurate, timely reporting for informed decision-making.

Categories

World
Crime
Finance
Tech and Science
Health
Sports
Entertainment
Lifestyle
Trending News

Company

About Us
Contact

Legal

Terms & Conditions
Privacy Policy

Follow Us

© 2026 The Financial Standard. All rights reserved.

biopharmaceutical acquisition | The Financial Standard

Home
>biopharmaceutical acquisition

Tag

biopharmaceutical acquisition

1 article

A composition of Gilead Sciences and Tubulis GmbH logos, alongside molecular models of Antibody-Drug Conjugates (ADCs) and a stylized representation of ovarian cancer cells, on a sleek, metallic laboratory bench.

Transformative Gilead Acquisition of Tubulis Signals Oncology Power Play

Gilead’s $5 billion acquisition of German biotech Tubulis for oncology expansion is a transformative move, bolstering it…

David Hale·April 8, 2026, 10:00 AM

Trending

US, Iran Exchange Strikes; Hormuz Tensions Escalate

July 12, 2026, 6:00 PM

Senator Lindsey Graham dies at 71 after sudden illness

July 12, 2026, 12:00 PM

NYT Journalists Subpoenaed Over Air Force One Security Report

July 11, 2026, 6:00 PM

US, Iran Conflict Escalates; Ceasefire Ends, Oil Surges

July 11, 2026, 12:00 PM

Millions face July 10 deadline for IRS COVID-19 tax refunds

July 10, 2026, 6:00 PM